Site icon The News Guy

23andMe heads to ESMO to tout its two clinical-stage drugs after scrapping discovery team – Endpoints News

Sign up for free to read a limited number of articles each month.

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=66e90dfd63cd4af784355cb8c6f28750&url=https%3A%2F%2Fendpts.com%2Fesmo24-23andme-heads-to-esmo-to-tout-its-two-clinical-stage-drugs-after-scrapping-discovery-team%2F&c=15110621261865988462&mkt=en-us

Author :

Publish date : 2024-09-16 17:59:00

Copyright for syndicated content belongs to the linked Source.

Exit mobile version